Rationale and design of the randomized, multicenter, open-label, controlled POLBOS 3 trial aimed to compare regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM C stent-Reference-Cited by-同舟云学术

Rationale and design of the randomized, multicenter, open-label, controlled POLBOS 3 trial aimed to compare regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM C stent

Published:2019-04 Issue:14 Volume:98 Page:e15106
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Gil Robert J.,Pawłowski Tomasz,Legutko Jacek,Lesiak Maciej,Witkowski Adam,Gąsior Mariusz,Kern Adam,Bil Jacek

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference18 articles.

1. Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM(R) stent: the randomised, multicentre, open-label, controlled POLBOS II trial;Gil;EuroIntervention,2016

2. Long-term effectiveness and safety of the sirolimus-eluting BiOSS LIM(R) dedicated bifurcation stent in the treatment of distal left main stenosis: an international registry;Gil;EuroIntervention,2016

3. Regular drug-eluting stent vs dedicated coronary bifurcation bioss expert stent: multicenter open-label randomized controlled POLBOS I trial;Gil;Can J Cardiol,2015

4. First-in-man study of dedicated bifurcation sirolimus-eluting stent: 12-month results of BiOSS LIM(R) Registry;Gil;J Interv Cardiol,2015

5. Dedicated bifurcation paclitaxel-eluting stent BiOSS Expert(R) in the treatment of distal left main stem stenosis;Bil;J Interv Cardiol,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Randomized, Multicenter, Open-Label, Controlled POLBOS 3 Trial Comparing Regular Drug-Eluting Stents and the Sirolimus-Eluting BiOSS LIM C Dedicated Coronary Bifurcation Stent: Four-Year Results;Biomedicines;2024-04-23

2. Novel Drug‐Eluting Stent Systems;Interventional Cardiology;2022-05-06

3. Polymer Coating Integrity, Thrombogenicity and Computational Fluid Dynamics Analysis of Provisional Stenting Technique in the Left Main Bifurcation Setting: Insights from an In-Vitro Model;Polymers;2022-04-22